Company intelligence / Profile preview
Lupin Limited
Mumbai, Maharashtra, Indialupin.com ↗
- Ownership
- Public · LUPIN
- Employees
- ~20000
- Development stage
- Other
01
Overview
Lupin is a global pharmaceutical company with a diverse portfolio of marketed products across multiple therapeutic areas. The company has filed 437 ANDA filings, 45 First-to-files and received 289 ANDA approvals[2].
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularRheumatologyEndocrinologyImmunologyDermatologyWomen's HealthNeurologyInfectious Diseases
- Modalities
- Small moleculesbiosimilarsgenericsbranded formulationsAPIsspecialty drugs
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
03
Financials
- Market cap
- $9.7B
- Total revenue
- $3B
- Enterprise value
- $9.4B
Beyond the preview
Go deeper on Lupin Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lupin Limited.